Sign inJoin waitlistJoin the waitlist

Sharon Sha

Associate Core Leader, Clinical Trials · Stanford Health Care

Credentials: · · · ·

History

Clinical Trials · Stanford Health Care
Present
Clinical Research · Stanford Health Care
Present
Huntington's Disease Center of Excellence · Stanford Health Care
Present

University of California-San Francisco
Neurology
UCLA and Stanford University
2010–2014
Stanford University School of Medicine
2006–2010
University of California-Los Angeles
2005–2008

Research

Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease
Cognitive and Behavioral Neurology · 2003 · 410 citations
Ultra-Low-Dose 18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs
Radiology · 2019 · 182 citations
Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features
Neurology · 2012 · First of 18 authors · Corresponding · 173 citations

Gil Rabinovici
29 papers
CO
Chiadikaobi Onyike
28 papers
David Wolk
28 papers
Lawrence Honig
28 papers · 26 as a resident
Mario Mendez
28 papers
Neill Graff-Radford
28 papers
Bradford Dickerson
27 papers
Paul Aisen
27 papers
Alireza Atri
26 papers
Dustin Hammers
26 papers
Erik Musiek
26 papers
Gregory Day
26 papers

Grants

Amyloid Clearing Therapy in Dementia with Lewy Bodies Plus Alzheimers Disease (ACT DLB+)
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $4.2M · Stanford University
2026–2033

Clinical trials

Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)
Principal investigator · Active not recruiting · Phase 3
AriBio Co., Ltd.
2022–2027
Clinical Trial Readiness for SCA1 and SCA3
Principal investigator · Unknown
The Methodist Hospital Research Institute
2018–2023